Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - epirubicin hydrochloride - solution for infusion - 2mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - epirubicin hydrochloride - solution for injection - 2mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - epirubicin hydrochloride - solution for injection - 2mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - epirubicin hydrochloride - solution for injection - 2mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - epirubicin hydrochloride - solution for infusion - 2mg/1ml

Israele - inglese - Ministry of Health

inovamed ltd - epirubicin hydrochloride - solution for injection - epirubicin hydrochloride 2 mg / 1 ml - epirubicin - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma high doses, ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.

Namibia - inglese - Namibia Medicines Regulatory Council

sandoz sa (pty) ltd - epirubicin - solution for infusion - each 100ml solution contains epirubicin hydrochloride 200,0 mg

Namibia - inglese - Namibia Medicines Regulatory Council

sandoz sa (pty) ltd - epirubicin - solution for infusion - each 50ml solution contains epirubicin hydrochloride 100,0 mg

Israele - inglese - Ministry of Health

novartis israel ltd - epirubicin hydrochloride - concentrate for solution for infusion - epirubicin hydrochloride 2 mg/ml - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma (high doses), ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of farmorubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after stransurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.

Canada - inglese - Health Canada

pfizer canada ulc - epirubicin hydrochloride - solution - 2mg - epirubicin hydrochloride 2mg - antineoplastic agents